62 studies found for:    HER2 and imaging
Show Display Options
Rank Status Study
1 Recruiting Pilot Imaging Study With 89Zr-Trastuzumab in HER2-positive Metastatic Breast Cancer Patients
Conditions: Breast Neoplasms;   Secondary;   HER2 Positive Carcinoma of Breast
Intervention: Drug: Zr89-trastuzumab
2 Completed PET Imaging With Cu-64 Labeled Trastuzumab in HER2+ Metastatic Breast Cancer
Condition: Breast Cancer
Intervention: Radiation: PET Imaging With Cu-64 Labeled Trastuzumab
3 Recruiting HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025
Condition: HER2-positive Breast Cancer
Intervention: Other: Radiolabeled [68Ga]ABY-025
4 Completed 89Zr-trastuzumab PET for Imaging the Effect of HSP90 Inhibition
Condition: Breast Cancer
Intervention: Other: Imaging with 89Zr-trastuzumab PET
5 Recruiting IMaging PAtients for Cancer Drug selecTion - Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Procedure: Molecular imaging
6 Active, not recruiting HER2 Imaging Study to Identify HER2 Positive Metastatic Breast Cancer Patient Unlikely to Benefit From T-DM1
Condition: HER-2 Positive Breast Cancer
Interventions: Drug: T-DM1;   Procedure: 89Zr-trastuzumab
7 Recruiting Imaging With 111 Indium (111In)-Pertuzumab (PmAb) to Predict Response to Trastuzumab (TmAb) in Human Epidermal Growth Factor-2 (HER2) Positive Metastatic Breast Cancer (MBC)
Condition: Breast Cancer
Intervention: Other: 111In-Pertuzumab + SPECT-CT
8 Recruiting 111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer
Condition: Breast Cancer
Interventions: Radiation: 111 Indium CHX-A DTPA-Trastuzumab;   Drug: 111Indium Trastuzumab
9 Recruiting Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting
Conditions: Breast Cancer;   HER2-negative Breast Cancer;   HER2-positive Breast Cancer;   Recurrent Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IIIC Breast Cancer
Interventions: Drug: Carboplatin;   Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Drug: bevacizumab;   Drug: trastuzumab;   Procedure: magnetic resonance imaging;   Procedure: therapeutic conventional surgery
10 Completed Biodistribution and Dosimetry of Serial PET Imaging With Ga-68 Labeled F(ab') 2- Trastuzumab
Condition: Solid Tumors
Intervention: Radiation: PET Imaging with Ga-68 Labeled F(ab') 2- Trastuzumab
11 Recruiting 89ZrTrastuzumab Breast Imaging With Positron Emission Tomography
Condition: Breast Cancer
Interventions: Drug: 89Zr-Trastuzumab Human Dosimetry and Safety;   Drug: HER2 Positive Lesion Detection and Safety
12 Recruiting PET Study of Breast Cancer Patients Using [68Ga]ABY-025
Condition: Breast Cancer
Intervention: Drug: [68Ga]ABY-025
13 Completed Exploratory Study of Breast Cancer With ABY025
Condition: Breast Cancer
Intervention: Drug: 111-In-ABY-025
14 Recruiting ImmunoTEP au 68-Ga- IMP-288 for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA
Condition: HER2 Negative Breast Carcinoma Expressing CEA
Intervention: Drug: TF2 - 68 Ga-IMP-288:
15 Not yet recruiting Strain Imaging in Breast Cancer Patients Receiving Trastuzumab
Condition: Her 2 Positive Breast Cancer
Intervention: Procedure: Transthoracic echocardiogram (ultrasound)
16 Unknown  Magnetic Resonance Imaging for the Early Detection of CNS Metastases in Women With Stage IV Breast Cancer
Conditions: Breast Cancer;   Metastatic Cancer
Interventions: Biological: trastuzumab;   Drug: chemotherapy;   Procedure: magnetic resonance imaging
17 Active, not recruiting Neoadjuvant Paclitaxel Versus BIBF 1120 Priming Followed by BIBF 1120 Plus Paclitaxel in Early HER-2 Negative Breast Cancer With Proteomic and Dynamic Imaging Correlates
Condition: Breast Cancer
Interventions: Drug: BIBF + Paclitaxel;   Drug: Paclitaxel
18 Recruiting MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer
Conditions: Estrogen Receptor-negative Breast Cancer;   HER2-negative Breast Cancer;   HER2-positive Breast Cancer;   Progesterone Receptor-negative Breast Cancer;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage II Breast Cancer;   Triple-negative Breast Cancer
Interventions: Procedure: Breast surgery;   Procedure: Magnetic resonance imaging;   Procedure: Mammography
19 Recruiting Benefits of Breast MRI for Predicting of Histopathologic Cell Type of Small Breast Cancer
Condition: Invasive Breast Cancer
Intervention: Radiation: MRI
20 Completed Detection of Amplification of Her2 Fluorescent in Situ Hybridization (FISH) in Breast Tissue Sections
Condition: Breast Cancer
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years